Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Shock. 2018 Feb;49(2):144-149. doi: 10.1097/SHK.0000000000000952.
The association between new-onset left ventricular (LV) dysfunction during sepsis with long-term heart failure outcomes is lesser understood.
Retrospective cohort study of all adult patients with severe sepsis and septic shock between 2007 and 2014 who underwent echocardiography within 72 h of admission to the intensive care unit. Patients with prior heart failure, LV dysfunction, and structural heart disease were excluded. LV systolic dysfunction was defined as LV ejection fraction <50% and LV diastolic dysfunction as ≥grade II. Primary composite outcome included new hospitalization for acute decompensated heart failure and all-cause mortality at 2-year follow-up. Secondary outcomes included persistent LV dysfunction, and hospital mortality and length of stay.
During this 8-year period, 434 patients with 206 (48%) patients having LV dysfunction were included. The two groups had similar baseline characteristics, but those with LV dysfunction had worse function as demonstrated by worse LV ejection fraction, cardiac index, and LV diastolic dysfunction. In the 331 hospital survivors, new-onset acute decompensated heart failure hospitalization did not differ between the two cohorts (15% vs. 11%). The primary composite outcome was comparable at 2-year follow-up between the groups with and without LV dysfunction (P = 0.24). Persistent LV dysfunction was noted in 28% hospital survivors on follow-up echocardiography. Other secondary outcomes were similar between the two groups.
In patients with severe sepsis and septic shock, the presence of new-onset LV dysfunction did not increase the risk of long-term adverse heart failure outcomes.
脓毒症患者新发左心室(LV)功能障碍与长期心力衰竭结局之间的关系尚未得到充分了解。
这是一项回顾性队列研究,纳入了 2007 年至 2014 年间所有在重症监护病房入院后 72 小时内接受超声心动图检查的严重脓毒症和脓毒性休克成年患者。排除了有既往心力衰竭、LV 功能障碍和结构性心脏病的患者。LV 收缩功能障碍定义为 LV 射血分数<50%,LV 舒张功能障碍定义为≥Ⅱ级。主要复合结局包括急性失代偿性心力衰竭的新住院治疗和 2 年随访时的全因死亡率。次要结局包括持续性 LV 功能障碍、住院死亡率和住院时间。
在这 8 年期间,共纳入了 434 例患者,其中 206 例(48%)患者存在 LV 功能障碍。两组患者的基线特征相似,但 LV 功能障碍组的功能更差,表现为 LV 射血分数、心指数和 LV 舒张功能障碍更差。在 331 例住院存活患者中,两组新发急性失代偿性心力衰竭住院率无差异(15% vs. 11%)。在有和没有 LV 功能障碍的两组患者中,2 年随访时主要复合结局相当(P=0.24)。在随访超声心动图中,有 28%的住院存活患者仍存在持续性 LV 功能障碍。其他次要结局在两组间相似。
在严重脓毒症和脓毒性休克患者中,新发 LV 功能障碍并不增加长期不良心力衰竭结局的风险。